Dengue Hemorrhagic Fever: Clinical Trials

2 trials for Dengue Hemorrhagic Fever, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Dengue Hemorrhagic Fever: new trials by email Literature Review of Dengue Hemorrhagic Fever trials Research Report on Dengue Hemorrhagic Fever

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus
DEN4 Vaccine Candidate, DEN4 Vaccine Placebo - Dengue Shock Syndrome, Dengue Hemorrhagic Fever
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)702009-07-012013-01-03
Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus
rDEN1delta30, rDEN2/4delta30(ME), Placebo to rDEN1delta30 or rDEN2/4delta30(ME) - Dengue Hemorrhagic Fever
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)362007-03-012010-12-14

Narrower conditions

Dengue (2)  ·  Severe Dengue (2)

Broader conditions

Arbovirus Infections (2)  ·  Flaviviridae Infections (2)  ·  Flavivirus Infections (2)  ·  Hemorrhagic Fevers, Viral (2)  ·  Infections (2)  ·  Mosquito-Borne Diseases (2)  ·  RNA Virus Infections (2)  ·  Vector Borne Diseases (2)  ·  Virus Diseases (2)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (2)

Countries

United States (2)

Top investigators

Anna Durbin, MD (2)  ·  Beth Kirkpatrick, MD (1)

Results publications

PMID 21208923